HRP20100097T1 - Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline - Google Patents

Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline Download PDF

Info

Publication number
HRP20100097T1
HRP20100097T1 HR20100097T HRP20100097T HRP20100097T1 HR P20100097 T1 HRP20100097 T1 HR P20100097T1 HR 20100097 T HR20100097 T HR 20100097T HR P20100097 T HRP20100097 T HR P20100097T HR P20100097 T1 HRP20100097 T1 HR P20100097T1
Authority
HR
Croatia
Prior art keywords
nonan
cyclopropyl
dihydro
oxo
fluoro
Prior art date
Application number
HR20100097T
Other languages
English (en)
Croatian (hr)
Inventor
Rast Hubert
Heep Iris
Grunenberg Alfons
Hallenbach Werner
Benet-Buchholz Jordi
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of HRP20100097T1 publication Critical patent/HRP20100097T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
HR20100097T 2004-04-01 2010-02-24 Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline HRP20100097T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004015981A DE102004015981A1 (de) 2004-04-01 2004-04-01 Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PCT/EP2005/002953 WO2005097789A1 (de) 2004-04-01 2005-03-19 Neue kristalline form von 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (1)

Publication Number Publication Date
HRP20100097T1 true HRP20100097T1 (hr) 2010-04-30

Family

ID=34962324

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100097T HRP20100097T1 (hr) 2004-04-01 2010-02-24 Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline

Country Status (32)

Country Link
US (1) US7977484B2 (no)
EP (1) EP1737859B1 (no)
JP (1) JP5190259B2 (no)
KR (1) KR101217678B1 (no)
CN (1) CN100591681C (no)
AR (2) AR048099A1 (no)
AT (1) ATE450536T1 (no)
AU (1) AU2005231918B2 (no)
BR (1) BRPI0509529B8 (no)
CA (1) CA2561635C (no)
CY (2) CY1109762T1 (no)
DE (3) DE102004015981A1 (no)
DK (1) DK1737859T3 (no)
ES (1) ES2335899T3 (no)
GT (1) GT200500043A (no)
HK (1) HK1104537A1 (no)
HR (1) HRP20100097T1 (no)
IL (1) IL178353A (no)
MY (1) MY140998A (no)
NO (1) NO337279B1 (no)
NZ (1) NZ550226A (no)
PE (1) PE20060170A1 (no)
PL (1) PL1737859T3 (no)
PT (1) PT1737859E (no)
RU (1) RU2383543C2 (no)
SI (1) SI1737859T1 (no)
SV (1) SV2006002070A (no)
TW (1) TWI350755B (no)
UA (1) UA84329C2 (no)
UY (1) UY28828A1 (no)
WO (1) WO2005097789A1 (no)
ZA (1) ZA200608072B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
WO2018146194A1 (en) 2017-02-13 2018-08-16 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin
CN115710267A (zh) * 2022-11-30 2023-02-24 天津大学 一种普拉沙星水合物晶体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0882049T3 (da) 1996-02-23 2003-03-03 Bayer Ag Eventuelt substituerede 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer og deres derivater
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
UY28828A1 (es) 2005-11-30
CY1109762T1 (el) 2014-09-10
UA84329C2 (en) 2008-10-10
BRPI0509529B1 (pt) 2019-05-21
RU2383543C2 (ru) 2010-03-10
US20080125458A1 (en) 2008-05-29
AU2005231918A1 (en) 2005-10-20
AR105177A2 (es) 2017-09-13
PE20060170A1 (es) 2006-04-13
GT200500043A (es) 2006-02-17
BRPI0509529B8 (pt) 2021-05-25
DE102004015981A1 (de) 2005-10-20
TWI350755B (en) 2011-10-21
AR048099A1 (es) 2006-03-29
RU2006138362A (ru) 2008-05-10
CN1938304A (zh) 2007-03-28
NO337279B1 (no) 2016-02-29
PL1737859T3 (pl) 2010-04-30
IL178353A (en) 2011-08-31
KR20070014157A (ko) 2007-01-31
BRPI0509529A (pt) 2007-09-18
CA2561635A1 (en) 2005-10-20
DE122011100055I1 (de) 2012-03-15
WO2005097789A1 (de) 2005-10-20
HK1104537A1 (en) 2008-01-18
ZA200608072B (en) 2008-01-08
NZ550226A (en) 2009-11-27
ES2335899T3 (es) 2010-04-06
CA2561635C (en) 2012-10-16
IL178353A0 (en) 2007-02-11
EP1737859B1 (de) 2009-12-02
SI1737859T1 (sl) 2010-03-31
MY140998A (en) 2010-02-12
JP5190259B2 (ja) 2013-04-24
SV2006002070A (es) 2006-03-15
JP2007530614A (ja) 2007-11-01
PT1737859E (pt) 2010-02-03
DE502005008620D1 (de) 2010-01-14
TW200602053A (en) 2006-01-16
DK1737859T3 (da) 2010-04-06
CY2011018I1 (el) 2016-12-14
CN100591681C (zh) 2010-02-24
KR101217678B1 (ko) 2013-01-02
US7977484B2 (en) 2011-07-12
NO20064988L (no) 2006-10-31
EP1737859A1 (de) 2007-01-03
ATE450536T1 (de) 2009-12-15
AU2005231918B2 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
GEP20105082B (en) (biphenyl) carboxylic acids and derivatives thereof
NO20085068L (no) Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
HRP20100097T1 (hr) Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline
AU2018236805B2 (en) Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
MY149731A (en) Compounds
HK1136827A1 (en) Spirocyclic cyclohexane derivatives
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
UA88481C2 (ru) Донепезила фумарат, пригодный для получения фармацевтических композиций
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
AU2010275640A8 (en) Benzoquinolizinium salt derivatives as anticancer agents
JP2008266291A5 (no)
MY165623A (en) 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
WO2010135505A3 (en) Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
EP1841729A4 (en) 2-CYCLOPENTENE-1-ONE OXIME DERIVATIVES INHIBITING TNF-ALPHA PRODUCTION
TH104388B (th) รูปผลึกแบบใหม่ของกรด 8-ไซยาโน-1-ไซโคลโพรพิล-7-(1s,6s-2,8-ไดอะซาไบไซโคล[4.3.0] โนแนน-8-อิล)-6-ฟลูออโร-1,4-ไดไฮโดร-4-ไดไฮโดร-4-ออกโซ-3-ควิโนลีนคาร์บอกซิลิก